home chevron_right About us chevron_right Partnerships

Partnerships

Partnerships

UPPTHERA realizes innovation in the drug development field based on targeted protein degradation (TPD) technology.

UPPTHERA is actively engaged in global business development (BD) activities along with R&D activities to maximize the pipeline value. And we are actively seeking partnerships with bio-tech and pharmaceutical companies, academic centers, universities, and other related organizations to enhance our treatment programs. Please contact us via email for R&D partnerships.

Major Strategic Partnerships

유한양행

염증관련 단백질 분해 PROTAC 기술이전 및 공동연구개발계약

(주)보령

IRF4 PROTAC 공동연구개발 및 사업화 계약

Hitgen (China)

Novel E3L binder Screening

디어젠(주)

특정 단밸질 타겟에 대한 PROTAC 공동연구개발 (A.I.-driven)

가천대 약학대학

신학연구 활성화를 위한 MOU 체결 동물실험 등 관련 연구 시설 지원

X-Chem (US)

Novel CRBN 플랫폼 공동연구개발

WuXi AppTec (China)

PROTAC 화합물 외주 합성

Major Investors